SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-14 |
| Reported value | $170,365,906 |
| Positions | 17 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| ALLOGENE THERAPEUTICS INC | ALLO | COM | $46,928,245 | 22,032,040 |
| CELCUITY INC | CELC | COM | $29,550,417 | 295,652 |
| ARVINAS INC | ARVN | COM | $27,662,520 | 3,457,815 |
| PYXIS ONCOLOGY INC | PYXS | COMMON STOCK | $19,480,773 | 7,032,770 |
| WAVE LIFE SCIENCES LTD | WVE | SHS | $10,931,250 | 1,875,000 |
| BIOHAVEN LTD | BHVN | COM | $8,004,360 | 505,645 |
| CARIBOU BIOSCIENCES INC | CRBU | COM | $7,879,924 | 4,690,431 |
| SPERO THERAPEUTICS INC | SPRO | COM | $5,338,906 | 2,362,348 |
| ZENTALIS PHARMACEUTICALS INC | ZNTL | COM | $3,853,489 | 953,834 |
| ORIC PHARMACEUTICALS INC | ORIC | COM | $3,553,775 | 372,904 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.